Tag Archive
Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical News Today)
MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company majority owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy. The application is based on the successful results of recent clinical trials involving patients with recurrent glioblastoma, an especially aggressive form of brain tumor… (read the story…) Related items MagForce Nanotechnologies... »
MagForce Nanotechnologies announces successful completion of its Nano-Cancer therapy trials (News-Medical-Net)
MagForce Nanotechnologies AG, the Berlin-based medical technology company majority owned by Nanostart AG, today announced the successful completion of final trials demonstrating the efficacy of its Nano-Cancer® therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. The actual study results significantly exceeded the study objective. (read the story…) Related... »
Nanostart Majority-Owned MagForce Announces Successful Completion of Final Clinical Trials For Nano-Cancer® Therapy (Business Wire via Yahoo! Finance)
FRANKFURT & BERLIN—-MagForce Nanotechnologies AG, the Berlin-based medical technology company majority owned by Nanostart AG, today announced the successful completion of final trials demonstrating the efficacy of its Nano-Cancer® therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. (read the story…) Related items MagForce Nanotechnologies announces successful completion of its... »
